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Acute mesenteric ischemia (AMI) is a life threatening cause of acute abdomen. The purpose of this study
is to deﬁne risk factors that predict the adverse outcome of AMI and to present our experience in the last
30 years. Hospital records and clinical data of 107 patients undergoing surgical intervention for AMI
during the last 30 year period were reviewed and clinical outcomes as well as factors inﬂuencing
mortality were analyzed. Mesenteric arterial thrombosis, arterial embolism and nonocclusive mesenteric
ischemia (NOMI) were the cause of AMI in 68 (63.6%), 28 (26%), and 11 patients (10.2%), respectively.
Abdominal pain was the most common presenting symptom (90.6%). Peritonitis was observed in 96
patients (89.7%) and 24 patients (22.4%) were in shock. Abdominal ultrasonography was performed in 46
patients (42%), abdominal CT angiography in 36 patients (33%) and mesenteric angiography in 12
patients (10.5%). All patients were operated and 11 (10%) patients underwent a second-look operation.
Bowel resection was necessary in 101 patients (93.4%) during the initial operation and in seven patients
(6.5%) during the second-look operation. The hospital mortality was 55.1%. Mortality was mainly due to
multiorgan failure (43%). Diabetes mellitus, use of digoxine and antiplatelet drugs, duration of the
symptoms until before surgery, existence of shock, low levels of the pH and bicarbonate and re-
laparotomy were found to be negative predictors of the perioperative mortality. The use of total
parenteral nutrition and CT angiography was found to be a protective factor against mortality. A high
index of suspicion with prompt diagnostic evaluation with CT angiography may reduce time prior to
surgical intervention which may lead to improved patient survival.
Published by Elsevier Ltd on behalf of Surgical Associates Ltd.1. Introduction
AMI is a life threatening cause of acute abdomen requiring early
surgical intervention. In recent years, the mortality of AMI has been
reported to vary from 60% to 90% in spite of the improved ﬂuid
management, respiratory care and nutritional support.1e6
AMI occurs when mesenteric vessels occlude due to mesenteric
arterial, venous thrombosis, arterial embolism and nonocclusive
mesenteric ischemia (NOMI).6e8 The occlusion of the intestinal
vessels causes the impairment of microcirculation of the intestine
with the activation of the endothelium, monocytes, leukocytes and
platelets.2,3,9,10 Activated inﬂammatory cells produce many medi-
ators such as cytokines, platelet eactivating factor, nitric oxide,
leukotriene and toxic free oxygen radicals. Leukocyte adhesion,
platelet aggregation and nitric oxide increase the damage of the
intestinal microcirculation.2,3,9 Toxic free oxygen radicals which
damage the cell membrane through lipid peroxidation cause anx: þ90 462 325 22 70.
@gmail.com (E. Alhan).
Ltd on behalf of Surgical Associatincrease in capillary permeability.10 The damaged intestinal
microcirculation with increased capillary permeability leads to the
bacterial translocation and this translocation may play an impor-
tant role in the development of sepsis resulting in multiple organ
failures and death.3,9,11
NOMI is deﬁned as a low cardiac output state associated with
diffuse mesenteric vasoconstriction. Mesenteric vasoconstriction
occurs in response to hypovolemia, myocardial infarction, conges-
tive heart failure, aortic insufﬁciency, renal or hepatic disease,
abdominal or cardiac surgery and vasopressor treatment.1e5 Vas-
oactice drugs such as digoxine, enteral nutrition in intensive care
units, multiple trauma are the other rare causes of NOM_I.2,3,6
The key points for recovery from this condition are early diag-
nosis, resection of the infarcted bowel, restoration of the blood
ﬂow, second-look laparotomy if necessary and supportive intensive
care.2e4,12,13 Most patients with AMI are admitted to the emergency
department with severe abdominal pain and signs of peritonitis.3,4
These patients with AMI are usually elderly and they usually have
a complex medical history. AMI has no speciﬁc symptoms or
pathognomonic clinical ﬁndings.12 Physical examination cannot
differentiate bowel ischemia from necrosis.2,12 Therefore thees Ltd.
Table 1
Demographics, and comorbidity, of our AMI patients and the causes of AMI. AMI;
acute mesenteric ischemia, SMA; superior mesenteric artery.
Total no (%) Alive (%) Dead (%) P
Number of patients 107 (100%) 48 (44.9) 59 (55.1) 0.03
Sex
Men 68 (63.6) 30 (44.1) 38 (55.9) NS
Women 39 (36.4) 17 (45) 22 (55) NS
Mean agea 69  8 68  8 70  9 NS
Hypertension 82 (76.6) 36 (43.9) 46 (56) NS
Chronic lung disease 31 (28.1) 15 (48.3) 16 (51.7) NS
Peripheric vascular disease 39 (36.4) 15 (38.5) 24 (61.5) NS
Diabetes mellitus 12 (11.4) 3 (25) 9 (75) 0.04
Atrial ﬁbrillation 84 (78.5) 27 (53.6) 57 (46.4) NS
Congestive heart failure 75 (70) 33 (44) 42 (56) NS
Coronary arterial diseases 46 (40.2) 21 (45.6) 25 (54.4) NS
Renal failure 6 (5) 3 (50) 3 (50) NS
Antiplatelet drugsb 74 (69.1) 20 (27) 54 (73) 0.04
Digoxin 56 (52.3) 16 (28.5) 40 (71.5) 0.03
Causes of AMI
SMA thrombosis 68 (63.6) 32 (47) 36 (53) NS
SMA embolus 28 (26.2) 15 (53.6) 13 (44.4) NS
Non-occlusive mesenteric 11 (10.2) 1 (9) 10 (91) 0.45
Ischemia
NS ¼ no signiﬁcant.
a Mean  standard deviation.
b Aspirin, dipyridamole, clopidogrel.
Table 2
Presenting symptoms, physical ﬁndings, laboratory results and between survivors
and non-survivors.
Total no (%) Alive (%) Dead (%) P
Duration of symptoms
prior to surgery (ha)
21  5 14  6 36  7 0.05
Abdominal pain 97(90.6) 40(84.2) 57(96.5) NS
Nausea and vomiting 52(48.5) 26(57.1) 26(44.4) NS
Abdominal distention 28(26.1) 12(25.7) 16(27.5) NS
Hematemesis 11(10.2) 5(11.4) 6(8.6) NS
Rectal bleeding 13(12.1) 7(14.2) 6(8.6) NS
Diarrhea 14(13) 7(14.2) 7(10.3) NS
Fever 16(14.9) 8(17.1) 8(13.7) NS
Shock 24(22.4) 4(8.5) 20(34.4) 0.04
Peritonitis 96(89.7) 48(100) 48(79.3) NS
CT angiography 36(33.6) 12(33.3) 24(66.6) 0.04
Body temperature, Ca 36.8  0.8 36.9  1.2 NS
Pulse rate, per mina 95  21 108  24 NS
Systolic blood pressure,
mmHga
129  13 107  14 0.03
Laboratory resultsa
Hemoglobin, g/dl 12.4  2.4 12.7  3 NS
WBC, mm3 17,800  4400 19,549  6400 NS
BUN, mg/dl 32  6 41  7 NS
Creatinine, mg/dl 1.7  0.3 2  0.3 NS
ALT, U/L 46  34 112  52 NS
Amylase, U/L 118  30 280  68 NS
CPK, U/L 425  478 1200  680 NS
Albumin, g/dl 3.2  0.3 3.1  0.4 NS
PH 7.42  0.14 7.18  0.13 0.03
Bicarbonate, mmol/L 20.9  2.1 10  3 0.04
a Mean  standard deviation.
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resulting in high mortality. That may be the reason why in the last
years the mortality rate has not changed much except in a few
limited series.1e6,8,14
The aim of this study was to present our thirty year experience
about the preoperative and postoperative prognostic factors of
early mortality in AMI and thus help the clinician in his/her ther-
apeutic decision making.
2. Patients and methods
The clinical records of all the patients who underwent surgical treatment for
AMI due to arterial embolism, thrombosis nonocclusive mesenteric ischemia
(NOMI) between April 30, 1980 and April 30, 2010, were examined. Patient’s
demographics, comorbidity, physical ﬁndings, laboratory test results, and diagnostic
imaging reports were reviewed. Initial admission laboratory test results were taken
into account. The data from operative records postoperative complications, second-
look laparotomies, mortality (in-hospital mortality after surgical treatment) and
hospital stay were recorded. Based on clinical, radiological, surgical and histological
ﬁndings patients were classiﬁed as having mesenteric emboli, arterial or venous
thrombosis or a NOMI.8,15
3. Statistical analysis
Data were analyzed using statistical package SPSS 13.01 for
windows (SPSS, Chicago, IL, USA, serial number 9069728). The chi-
squared test or Fisher’s test was used to compare categorical data.
For the parametric distribution of values, Student t-test or analysis
of variance (ANOVA) was used to compare the mean values of two
or more groups. For the nonparametric variables, the
KruskaleWallis test or ManneWhitney U test was used to compare
the median values of the response variable. A stepwise logistic
regression analysis was performed. The test results were
considered signiﬁcant at a P value of less than 0.05.
4. Results
Sixty eight patients were men (63.6%) and 39 were women
(36.4). The mean  SD age was 69  8 with the range of 39e92
years. Superior mesenteric artery (SMA) thrombosis was the most
common form of AMI and was seen in 68 patients (68.6). 28
patients (%26.2) had SMA embolism, and 11 patients (10.2%) had
NOM I (Table 1).
Demographic data and concomitant illness related mortality are
given in Table 1. Diabetes mellitus, the use of antiplatelet drugs
such as aspirin, dipyridamole, clopidogrel in our country and
digoxin were related with perioperative mortality. Ninety seven
patients (90.6%) were admitted to the emergency department with
acute abdominal pain. Presence of shock and interval between the
beginning of symptoms and the onset of the operation were
statistically associated with mortality (Table 2). 96 patients (89.7%)
had signs of peritonitis during the initial abdominal examination.
Other symptoms and physical ﬁndings are summarized in Table 2.
Preoperative laboratory ﬁndings related to mortality rate are
shown in Table 2. pH and bicarbonate levels were signiﬁcantly
associated with mortality.
All our patients with NOMI were followed in intensive care units
by departments of cardiology and anaesthesiology. These patients
underwent laparotomy since acute abdomen could not be
excluded.
We performed plain abdominal radiography on 90 patients
(84.3%)and abdominal ultrasonography on 46 patients (42%). Since
1999 abdominal CT angiography was done in 36 patients (33%) and
mesenteric angiography was performed on 12 patients (10.5%).
Laparotomy was performed on all patients, of which 11 were
taken a second-look and underwent resection. Surgical procedures
are shown in Table 3. Bowel resection was performed in 101patients (93.4%). Laparotomy was performed on the rest of the
patients (six patients) but bowel resection was not done due to the
massive gastrointestinal necrosis. End colostomy was performed in
one patient. The type of anastomosis, whether stapled or hand-
made had no effect on mortality.
59 patients died in the postoperative period due to the AMI.
Therefore the operative mortality was 55.1%. Themortality ratewas
53% in patients with thrombosis, 44.4% in patients with arterial
embolism and 91% in patients with NOMI. The type of ischemiawas
Table 3
Comparison of surgical procedures, postoperative care between survivors and non-
survivors with acute mesenteric ischemia.
Total no (%) Alive (%) Dead (%) P
Unresectable 6 (5.6) 0 (0) 6 (100) 0.03
Left hemicolectomy
with end colostomy
1 (0.9) 1 (100) 0 (0) NS
Jejunosigmoideostomy
after jejunoeileoecolic
resection
4 (3.7) 0 (0) 4 (100) 0.03
Duodenotransversostomy
after jejunoeileoecolic
resection
2 (1.8) 0 (0) 2 (100) NS
Jejunoileostomy after
jejunoileal resection
26 (24.2) 14 (53.8) 12 (44.2) NS
Jejuno transversostomy
after jejunoeileoecolic
resection
68 (63.5) 32 (46.4) 36 (53.6) NS
Sutured anastomosis 80 (74.7) 36 (45) 44 (55) NS
Stapled anastomosis 25 (23.3) 10 (40) 15 (60) NS
Relaporotomy 11 (10.2) 4 (36.3) 7 (63.7) 0.05
Use of total parenteral nutrition 37 (34.5) 25 (67.5) 12 (32.5) 0.045
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although patients with superior mesenteric arterial thrombosis
seemed to have a higher mortality rate. Only one patient with
NOMI survived (Table 1, P < 0.05). The causes of death have been
shown in Table 4. Most of the patients died due to multiorgan
failure. The second cause of the mortality was cardiogenic
problems.
These results were used to create a logistic regression model to
predict the risk of perioperative mortality. Existence of diabetes
mellitus, use of digoxin and antiplatelet drugs, duration of symp-
toms prior to surgery, existence of preoperative shock, low levels of
pH and bicarbonate, re-laparotomy were found to be negative
predictors of the perioperative mortality. The use of total parenteral
nutrition and CT angiography was found to be protective factors
against mortality.5. Discussion
AMI is a lethal surgical disease that results in mortality in most
patients if not immediately treated. Ottinger and Austen reported
in 1967 a rate of 8.8 cases of AMI per 100,000 hospital admissions
and 30 years later Stoncy and Cunningham reported a higher rate
of 1 in 1000 hospital admissions.8,16,17 Due to the low incidence
and broad spectrum of AMI, there are not any controlled and
randomized studies in the literature. Therefore most of the
knowledge about AMI is based on retrospective series like
ours.4,5,8
Most of these patients, who were affected with AMI, are often
from the elderly and medically compromised population. These
risk factors have a negative effect in the outcome.7,14 However, we
found only a two year difference in age between those whoTable 4
Cause of death.
Number %
Multiorgan failure 25 43
Cardiac 13 21
Sepsis 10 17
Respiratory failure 6 11
Renal failure 2 3
Unknown 3 5survived and died and this difference was statistically insigniﬁcant
(P > 0.05). Age should not be considered as a contraindication for
surgery. We observed a previous history of cardiac diseases such
as atrial ﬁbrillation in 78.5%, hypertension in 76.6%, congestive
heart failure in 70%, coronary arterial diseases in 40.2% and use of
antiplatelet drugs in 69%, digoxine in 52.3% of our patients. Similar
observations were done in many other studies.14e19 Park et al. and
Merida et al. found previous history of cardiac disease to be an
independent risk factor, but in our study we could not verify this
relation.14,19 On the other hand, we observed a signiﬁcant relation
between the use of antiplatelet drugs and digoxine and mortality
which Huang et al. were not able to show.18 In addition, in the last
three decades many new drugs have been used for the prophylaxis
and treatment of the AMI such as aspirin, dyprimadole, clopi-
dogrel, heparin, low molecular weight heparin.3 The discovery of
new drugs has not prevented the occurrence of AMI but the use of
antiplatelet drugs needs to be considered on the diagnosis
of AMI.20
Patients with AMI in this study had severe abdominal pain in
90.6% of the patients, nausea and vomiting in 48.5%, diarrhea in
13%, rectal bleeding in 12% and hematemesis in 10.2% (Table 2).
Laboratory investigations revealed leukocytosis, elevated levels of
liver enzymes, as well as creatinine phosphokinase, serum urea,
creatinine, amylase, and acidosis. Peritonitis existed in 89.7% of our
patients and shock in 22.4% during the initial physical examination.
In some series, it was reported that abdominal pain and tenderness,
high leukocyte counts were found to be associated with higher
mortality.13,15,18,19 We did not observe such a relationship. Mamode
et al. suggest that patients with elevated leukocyte levels have
lower mortality rates than those with low leukocyte counts.15
Greenwald et al. explained high leukocyte counts with presence
of intestinal necrosis.21 We couldn’t ﬁnd a relationship between
high leukocyte counts and mortality in our study. Elevated levels of
serum urea and creatinine were also considered to be bad prog-
nostic factors as far as mortality is considered.19,22 We did not
observe this in our study. However, acidosis was found to be
associated with perioperative mortality both in our study and in
two other studies.15,18,19
Our centre is a hospital afﬁliated with a university which gives
service to about ﬁve million people in this geographical setting
which has not been reported as a proven factor affecting the
outcomes. The patients included in this study were collected in all
seasonal times of a 30 years period as mentioned in the title. The
possible delays in decision making and surgical intervention may
be related with the ineffective referral process of the health care
system. Delay in operative intervention was closely related with
high mortality in our study. Other recently published studies also
conﬁrm our results.4,5,15,18,19
Among diagnostic imaging studies, angiography is the gold
standard for diagnosing AMI.18 In addition angiography provides an
advantage as a therapeutic modality.4 Although routine angiog-
raphy decreases the mortality rate in AMI patients, the role of
angiography is still controversial in patients with peritoneal signs.4
Moreover, it is impossible to perform selective angiography for
every patient with suspected AMI in many hospitals. Some physi-
cians even claim that performing angiography will delay surgical
treatment for critically ill patients and they recommend taking the
patient directly to surgery.23 We used diagnostic angiography only
in a few patients, because most of our patients (89.7%) had peri-
tonitis. In the recent years, we used CT angiography in 33% of our
patients with new generation CT scan equipment.24,25 Our CT
angiography results revealed 100 percent correct diagnosis. The use
of CT angiography signiﬁcantly reduced mortality rate (P < 0.05,
Table 2). Our results were in parallel and supported by the results of
Acosta et al.7 CT angiography helped the decision of early surgical
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vessels.
The treatment of AMI begins with early diagnosis, followed by
ﬂuid resuscitation, invasive hemodynamic monitoring, prophy-
lactic antibiotics, and systemic anticoagulation with hep-
arin.2e6,12,13,26 Then resection of infarcted bowel, restoration of
blood ﬂow, preservation of small bowel length and supportive
intensive care are the basis of surgical management.2e6,12,26 We
performed laparotomy and bowel resection in most of the patients,
because 89.1% of our patients had signs of peritonitis on initial
physical examination and bowel necrosis was found in all of them
at laparotomy. This was one reason why we could not use any
revascularization or bypass procedure in our patients. The reason
for this high incidence of bowel necrosis is mainly due to late
referral of AMI patients to our hospital, a level one university
hospital. Second-look operation was performed on only 11 patients
because of clearly marked demarcation of the intestine at the time
of ﬁrst operation.13
The restoration of the blood ﬂow can be provided by revascu-
larization or bypass surgery. Revascularization or bypass surgery in
AMI is still controversial in the literature because they are not as
successful as in coronary artery diseases.6,12,26 While the restora-
tion of blood ﬂow improves the microcirculation of the intestine, it
may lead to reperfusion injury and distant organ damage.9 Park
et al. reported the lowest mortality rate (32%) with limited number
of series in the literature with revascularization procedures.14 We
could not undergo revascularization procedures on our patients
because the majority of themwere admitted very late with massive
necrosis.
The prognosis of the AMI is dismal. And the perioperative
mortality rates vary between 59% and 93%, an average of 71% in the
last 30 years.4,14,27 Some new studieswith surgical revascularization
procedures claim to have mortality rates of 32% and 38%.4,14
However, those series have limited number of cases. Although no
revascularization procedures were performed in our series, our
mortality rate is lower than the average rate cited in the literature.
Ourmortality ratewas 55.1%. This mortality rate is acceptablewhen
comparedwith the literature’s average of 71%.Weprobably owe this
lower rate of mortality to our rapid surgical intervention approach.
We acknowledge that, to improve our survival rates still further we
may have to use revascularization procedures such as balloon
catheter thromboembolectomy, mesenteric bypass, angioplasty,
endarterectomy, reimplantation, and endovascular therapy. On the
other hand, we strongly believe that, to really make a difference in
decreasing mortality from AMI we have to decrease its incidence.
This endpoint can be met by treating the underlying causes of AMI
anddoing timely revascularizationof the symptomaticpatientswith
chronic mesenteric occlusive disease before AMI sets in.
We conclude that the use of antiplatelet drugs and digoxin,
presence of diabetes mellitus, presence of shock and acidosis,
duration of symptoms prior to surgical intervention are adversely,
use of abdominal CT angiography for diagnosis and use of post-
operative total parenteral nutrition are favorably related with
mortality in our study. Diagnosis and successful treatment of AMI
require a high index of clinical suspicion that will enable rapid
surgical intervention followed by aggressive postoperative care to
prevent multiorgan failure and mortality.
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